chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination error
Clinical narrative: Pfizer vaccine mixed incorrectly (used sterile water)
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Eye pain, Pain, Pain in extremity
Clinical narrative: Sore left eye which lasted 5 days. Sporadic shoulder and arm pain for the 1st 7 days; has now started to get progressively worse.  Constant throbbing pain from the shoulder through the tips of my fingers.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Paraesthesia oral, Pruritus
Clinical narrative: Vaccination was received on Wednesday afternoon. That Friday night at 11pm I felt tingling around my mouth. I developed nausea and lightheadedness/dizziness at about 12:00 am and the tingling became severe itching that spread gradually to the rest of my body without any visible rash, from my scalp down to my knees, slightly less severe on my feet and soles, and lasted some 36 hours. I visited an emergency center Saturday morning due to extreme discomfort and received a steroid injection and hydroxyzine HCl tablets. Itching continued through the rest of the day and gradually diminished, ending by Sunday mid afternoon.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Seizure
Clinical narrative: Patient is 21 y/o male presenting to pharmacy for COVID vaccination, received vaccine at 1500, shortly after administration of vaccine (roughly 1503), patient experienced brief tonic/clonic seizure, total time of seizure less than 20 seconds, seizure resolved spontaneously. EMT's were dispatched to location, ER visit/hospitalization deemed unnecessary. Patient stayed at the pharmacy for the remainder of the 30 minute observation period with no significant events. Patient and parents mentioned history of seizure after vaccination, though specific product could not be recalled. Patient has no formal diagnosis of seizure disorder, which was confirmed by medical testing completed in childhood, and has no history of antiepileptic medication.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Product administered to patient of inappropriate age, Skin abrasion, Skin laceration, Syncope
Clinical narrative: Brief syncopal episode, fell from chair, struck head on floor, suffered small laceration and abrasion to left eyebrow.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Allergy to arthropod bite, Eye swelling, Rash, Rash erythematous
Clinical narrative: Had a small rash on arm for a couple of days after the vaccine but now I am having severe allergic reactions to mosquito bites.   Eyes swell shut if bitten on face, large (4 inches on top and bottom, 3 inches on sides) red raised bumps if on body.  I have never had reactions like this pre-vaccine.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death, Dialysis, Dyspnoea, Myocardial infarction, Oropharyngeal pain
Clinical narrative: on 4/20/21,  9 am (24hrs after receiving the second shot, he complained that the couldn't breath and his throat hurt, we gave him some tylenol,) then we call 911 by 3pm because he looked pale.  by 6pm we were told that he was going uptown, because he might need a ventilator.  Then at 12:30 a.m. on 4/21/21 we were told he was alert and in emergency diaylsis and he should be okay.  Then they called us at 8 a.m. to say that he had passed away due to a heart attack.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pallor
Clinical narrative: on 4/20/21,  9 am (24hrs after receiving the second shot, he complained that the couldn't breath and his throat hurt, we gave him some tylenol,) then we call 911 by 3pm because he looked pale.  by 6pm we were told that he was going uptown, because he might need a ventilator.  Then at 12:30 a.m. on 4/21/21 we were told he was alert and in emergency diaylsis and he should be okay.  Then they called us at 8 a.m. to say that he had passed away due to a heart attack.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea
Clinical narrative: on 4/20/21,  9 am (24hrs after receiving the second shot, he complained that the couldn't breath and his throat hurt, we gave him some tylenol,) then we call 911 by 3pm because he looked pale.  by 6pm we were told that he was going uptown, because he might need a ventilator.  Then at 12:30 a.m. on 4/21/21 we were told he was alert and in emergency diaylsis and he should be okay.  Then they called us at 8 a.m. to say that he had passed away due to a heart attack.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Pfizer vaccine mixed incorrectly (used sterile water)
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphonia, Throat irritation
Clinical narrative: THROAT DEVELOPED A TICKLE, 4 HOURS LATER THROAT FELT ITCHY, RASPY VOICE. EVALUATED IN AN CARE SETING. EPI SHOT GIVEN, IV MEDS, AND A PRESCRIPTION SENT WITH THE INDIVIDUAL.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Hyperhidrosis, Loss of consciousness
Clinical narrative: About 5 minutes after shot, the patient's mother alerted us to her daughter being unconscious.  She was sitting in a chair slumped forward, we pushed her back in the chair.  The patient was tensed up, sweaty, with labored breathing. She was assessed to not  to be in respiratory distress and held so she wouldn't slide out of the chair she was sitting in. She began to return to consciousness and pulse seemed relatively normal with breathing returning to normal after 3 minutes.  Local EMS was activated.  The patient was given cold water to hold on her neck and was alert.  Local EMS assessed she was ok and the patient's mother refused transport to the ED.  The patient left on her own.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Electrocardiogram, Headache, Insomnia
Clinical narrative: - sleeplessness, headache and night sweats - 5/17/21 8PM - 6AM - passed out - 5/18/21 6:30AM - light headed and headache - 5/18/21 7AM - 10PM - shortness of breath when talking - 5/19/21 10AM - 6PM - headache has dissipated - 5/19/21 12PM
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Loss of consciousness, Night sweats
Clinical narrative: - sleeplessness, headache and night sweats - 5/17/21 8PM - 6AM - passed out - 5/18/21 6:30AM - light headed and headache - 5/18/21 7AM - 10PM - shortness of breath when talking - 5/19/21 10AM - 6PM - headache has dissipated - 5/19/21 12PM
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Vaccine administered 6 days early per patient's request
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash 2 days post 2 nd dose of Pfizer Vaccine.  Treated with Prednisone taper and Benadryl
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Interchange of vaccine products, No adverse event
Clinical narrative: Client received 1st dose of  Pfizer on 04/28/2021. Client went through J&J vaccine line and verified with staff that they were receiving J&J vaccine. Client then received J&J vaccine, was observed for 30 minutes. No adverse reaction.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: Patient developed a delayed localized hypersensitivity reaction
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis, Headache
Clinical narrative: Severe epistaxis, bloody nose, headache
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Pfizer vaccine mixed incorrectly (used sterile water)
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood thyroid stimulating hormone, Computerised tomogram head, Dizziness, Fatigue, Full blood count
Clinical narrative: DIZZINESS, FATIGUE
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Metabolic function test
Clinical narrative: DIZZINESS, FATIGUE
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Influenza like illness, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: 1st Vaccine, Soreness in Arm, Fatigue, Insomnia and welt on injection site with redness and itchiness lasted for 10 years, Menstruation cycle was sever - increased in mirgraine, fatigue, and bleeding 2nd Vaccine - Fatigue, Insonmia, Fever, Flu like symptoms, breakthrough bleeding in between mentruation cycles. Injectiong site size of a baseball including rediness and soreness
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Insomnia, Menstrual disorder, Pyrexia
Clinical narrative: 1st Vaccine, Soreness in Arm, Fatigue, Insomnia and welt on injection site with redness and itchiness lasted for 10 years, Menstruation cycle was sever - increased in mirgraine, fatigue, and bleeding 2nd Vaccine - Fatigue, Insonmia, Fever, Flu like symptoms, breakthrough bleeding in between mentruation cycles. Injectiong site size of a baseball including rediness and soreness
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Herpes zoster
Clinical narrative: shingles, weakness, and tiredness.
Age: 72.0
Sex: F
Vaccine: COVID19, TDAP
Symptoms: Extra dose administered
Clinical narrative: PATIENT CAME 5/19 FOR ADACEL VACCINE BUT PHARMACIST GAVE PATIENT 3RD DOSE OF MODERNA COVID 19 SHOT. PATIENT RECEIVED 2 DOSE OF MODERNA COVID 19 SHOT IN APRIL
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination error
Clinical narrative: Pfizer vaccine mixed incorrectly (used sterile water)
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Influenza like illness
Clinical narrative: Severe fatigue, headaches, flu like symptoms
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram thorax, Dizziness, Hyperhidrosis, Pallor, Vision blurred
Clinical narrative: Dizziness, sweaty, blurred vision approx 2 mins after getting vaccine. Brought over to medical.  Patient was alert, pale and diaphoretic.  Patient was given water, crackers, alert and talkative, feeling much better. Patient sent home  Past Medical Hx Had presyncope episodes with vaccine/blood draws in the past No recent illness and ate today
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: When administering the vaccine the needles detached from the syringe causing the vaccine to not enter the patient.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Herpes zoster
Clinical narrative: Three weeks after second dose of phizer vaccine I got shingles
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Pt was given 2 doses of Moderna and is under the age of 18
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site bruising, Injection site induration, Injection site pain, Pruritus, Skin discolouration
Clinical narrative: Bright pink discoloration of skin and swelling, with itching, soon after injection. Felt like there was a lump or knot the size of a marble under site.  Lasted two weeks. At three weeks site is discolored and looks bruised. Is faintly sore to the touch.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Skin swelling
Clinical narrative: Bright pink discoloration of skin and swelling, with itching, soon after injection. Felt like there was a lump or knot the size of a marble under site.  Lasted two weeks. At three weeks site is discolored and looks bruised. Is faintly sore to the touch.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Influenza A virus test negative, Influenza B virus test, Respiratory viral panel, SARS-CoV-2 test positive
Clinical narrative: UNKNOWN
Age: 27.0
Sex: M
Vaccine: UNK
Symptoms: Fatigue, Pyrexia, Sleep paralysis
Clinical narrative: Sleep Paralysis Fever Fatigue
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Nausea
Clinical narrative: Client received first dose of COVID vaccine @ 10:10am and complained of dizziness and nausea @ 10:25am.  Client assisted to zero-gravity chair and given a cold ice pack.  Vital signs assessed, initial blood pressure 77/50.  Client reports only eating grapes prior to vaccine, snack and water offered. Client denies shortness of breath, no medical conditions, not taking medications, no know allergies.  Client complained of abdominal pain that comes and goes @1029, reports no longer dizzy or nauseous.  Blood pressure at the time is 98/65.  Continued to monitor client, vital signs and blood pressure 105/65 @ 1039.   Client reports no more symptoms @ 1050, able to walk out of observation area with steady gait.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: No adverse symptoms aware of. Patient was stuck twice by provider. 1st injection was with an empty syringe. 2nd injection was with the medication.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Pfizer vaccine mixed incorrectly (used sterile water)
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Injection site pain, Pharyngeal swelling, Pyrexia
Clinical narrative: Approximately 12 hours after injection, began to run fever over 101 degrees and have severe chills and shaking. Soreness at injection site became inability to lift left arm, along with continued fever, fatigue, and chills for approximately 24 hours.   Approximately 9 days after, became fatigued again, fever of around 100 degrees off and on, and swelling in tonsils/throat, in spite of very limited exposure to other individuals.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Tonsillar hypertrophy
Clinical narrative: Approximately 12 hours after injection, began to run fever over 101 degrees and have severe chills and shaking. Soreness at injection site became inability to lift left arm, along with continued fever, fatigue, and chills for approximately 24 hours.   Approximately 9 days after, became fatigued again, fever of around 100 degrees off and on, and swelling in tonsils/throat, in spite of very limited exposure to other individuals.
Age: 17.0
Sex: M
Vaccine: UNK
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient was not at the indicated age for the moderna vaccine (18 requirement 18) at this time
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Scan normal
Clinical narrative: About 5 pm on 4/13 my right upper calf started having a pain.  Its still hurting today.  sent me for imaging.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Chest pain, Ejection fraction normal, Electrocardiogram PR shortened, Electrocardiogram abnormal
Clinical narrative: Patient is a 21 y.o. male with no past medical history who got his second dose of COVID (Pfizer) vaccine on Saturday presented with chest pain since Sunday. Patient says that he was in his USOH until yesterday when he started having substernal chest pain which was getting worse with inspiration but also with specific movements. He does have pain even at rest sometimes but he thinks that it's exacerbating by breathing. Had some nausea/vomiting as well. Denies other symptoms. Not really sob or leg swelling.    In the ER, his Trop I was 10.7 and his WBC was 12.2. His EKG was NSR with short PR and STE I, II, III, AVF, V4-V6  Patient is a 21 y.o. male with no past medical history who got his second dose of COVID (Pfizer) vaccine on Saturday presented with chest pain since Sunday with some pleuritic characteristics. He was found to have a very elevated trop I to 10.7, leukocytosis to 12.2 and STE in I, II, III, AVF, V4-V6. His POCUS in the ER was without significant pericardial effusion and probably normal EF. Differential at this point includes pericarditis vs myopericarditis (there are some myocarditis cases reported in Israel post Pfizer vaccination, predominantly in young male patients) vs less likely ACS. Will need admission and further work up and treatment        -Admission to Cardiology -NPO in case team tomorrow decides to proceed to LHC  -Full echo and cardiac MRI tomorrow  -Telemetry monitoring  -Repeat EKG q4h overnight  -send CRP, ESR -trend Trop to peak  -would not start heparin gtt at this point  -Please start tonight ASA 650 TID + Colchicine 0.6 mg BID   21-year-old man admitted with signs and symptoms of acute myo-pericarditis or in the setting of recent COVID-19 vaccination.  He apparently had the findings are vaccine 2 days ago and developed pleuritic chest pain.  His ECG shows pathognomonic changes for pericarditis in the is a small troponin elevation.  He has no past medical history or exertional symptoms to suggest CAD.  Bedside echocardiogram showed preserved left ventricular systolic function.  He was admitted and placed on aspirin and colchicine.  A cardiac MRI today showed evidence of myopericarditis.  He had 3 beats of nonsustained VT on tele.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Leukocytosis, Myocarditis, Nausea, Pain, Painful respiration
Clinical narrative: Patient is a 21 y.o. male with no past medical history who got his second dose of COVID (Pfizer) vaccine on Saturday presented with chest pain since Sunday. Patient says that he was in his USOH until yesterday when he started having substernal chest pain which was getting worse with inspiration but also with specific movements. He does have pain even at rest sometimes but he thinks that it's exacerbating by breathing. Had some nausea/vomiting as well. Denies other symptoms. Not really sob or leg swelling.    In the ER, his Trop I was 10.7 and his WBC was 12.2. His EKG was NSR with short PR and STE I, II, III, AVF, V4-V6  Patient is a 21 y.o. male with no past medical history who got his second dose of COVID (Pfizer) vaccine on Saturday presented with chest pain since Sunday with some pleuritic characteristics. He was found to have a very elevated trop I to 10.7, leukocytosis to 12.2 and STE in I, II, III, AVF, V4-V6. His POCUS in the ER was without significant pericardial effusion and probably normal EF. Differential at this point includes pericarditis vs myopericarditis (there are some myocarditis cases reported in Israel post Pfizer vaccination, predominantly in young male patients) vs less likely ACS. Will need admission and further work up and treatment        -Admission to Cardiology -NPO in case team tomorrow decides to proceed to LHC  -Full echo and cardiac MRI tomorrow  -Telemetry monitoring  -Repeat EKG q4h overnight  -send CRP, ESR -trend Trop to peak  -would not start heparin gtt at this point  -Please start tonight ASA 650 TID + Colchicine 0.6 mg BID   21-year-old man admitted with signs and symptoms of acute myo-pericarditis or in the setting of recent COVID-19 vaccination.  He apparently had the findings are vaccine 2 days ago and developed pleuritic chest pain.  His ECG shows pathognomonic changes for pericarditis in the is a small troponin elevation.  He has no past medical history or exertional symptoms to suggest CAD.  Bedside echocardiogram showed preserved left ventricular systolic function.  He was admitted and placed on aspirin and colchicine.  A cardiac MRI today showed evidence of myopericarditis.  He had 3 beats of nonsustained VT on tele.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Pericarditis, Pleuritic pain, Troponin I increased, Ultrasound scan normal, Ventricular tachycardia
Clinical narrative: Patient is a 21 y.o. male with no past medical history who got his second dose of COVID (Pfizer) vaccine on Saturday presented with chest pain since Sunday. Patient says that he was in his USOH until yesterday when he started having substernal chest pain which was getting worse with inspiration but also with specific movements. He does have pain even at rest sometimes but he thinks that it's exacerbating by breathing. Had some nausea/vomiting as well. Denies other symptoms. Not really sob or leg swelling.    In the ER, his Trop I was 10.7 and his WBC was 12.2. His EKG was NSR with short PR and STE I, II, III, AVF, V4-V6  Patient is a 21 y.o. male with no past medical history who got his second dose of COVID (Pfizer) vaccine on Saturday presented with chest pain since Sunday with some pleuritic characteristics. He was found to have a very elevated trop I to 10.7, leukocytosis to 12.2 and STE in I, II, III, AVF, V4-V6. His POCUS in the ER was without significant pericardial effusion and probably normal EF. Differential at this point includes pericarditis vs myopericarditis (there are some myocarditis cases reported in Israel post Pfizer vaccination, predominantly in young male patients) vs less likely ACS. Will need admission and further work up and treatment        -Admission to Cardiology -NPO in case team tomorrow decides to proceed to LHC  -Full echo and cardiac MRI tomorrow  -Telemetry monitoring  -Repeat EKG q4h overnight  -send CRP, ESR -trend Trop to peak  -would not start heparin gtt at this point  -Please start tonight ASA 650 TID + Colchicine 0.6 mg BID   21-year-old man admitted with signs and symptoms of acute myo-pericarditis or in the setting of recent COVID-19 vaccination.  He apparently had the findings are vaccine 2 days ago and developed pleuritic chest pain.  His ECG shows pathognomonic changes for pericarditis in the is a small troponin elevation.  He has no past medical history or exertional symptoms to suggest CAD.  Bedside echocardiogram showed preserved left ventricular systolic function.  He was admitted and placed on aspirin and colchicine.  A cardiac MRI today showed evidence of myopericarditis.  He had 3 beats of nonsustained VT on tele.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting, White blood cell count increased
Clinical narrative: Patient is a 21 y.o. male with no past medical history who got his second dose of COVID (Pfizer) vaccine on Saturday presented with chest pain since Sunday. Patient says that he was in his USOH until yesterday when he started having substernal chest pain which was getting worse with inspiration but also with specific movements. He does have pain even at rest sometimes but he thinks that it's exacerbating by breathing. Had some nausea/vomiting as well. Denies other symptoms. Not really sob or leg swelling.    In the ER, his Trop I was 10.7 and his WBC was 12.2. His EKG was NSR with short PR and STE I, II, III, AVF, V4-V6  Patient is a 21 y.o. male with no past medical history who got his second dose of COVID (Pfizer) vaccine on Saturday presented with chest pain since Sunday with some pleuritic characteristics. He was found to have a very elevated trop I to 10.7, leukocytosis to 12.2 and STE in I, II, III, AVF, V4-V6. His POCUS in the ER was without significant pericardial effusion and probably normal EF. Differential at this point includes pericarditis vs myopericarditis (there are some myocarditis cases reported in Israel post Pfizer vaccination, predominantly in young male patients) vs less likely ACS. Will need admission and further work up and treatment        -Admission to Cardiology -NPO in case team tomorrow decides to proceed to LHC  -Full echo and cardiac MRI tomorrow  -Telemetry monitoring  -Repeat EKG q4h overnight  -send CRP, ESR -trend Trop to peak  -would not start heparin gtt at this point  -Please start tonight ASA 650 TID + Colchicine 0.6 mg BID   21-year-old man admitted with signs and symptoms of acute myo-pericarditis or in the setting of recent COVID-19 vaccination.  He apparently had the findings are vaccine 2 days ago and developed pleuritic chest pain.  His ECG shows pathognomonic changes for pericarditis in the is a small troponin elevation.  He has no past medical history or exertional symptoms to suggest CAD.  Bedside echocardiogram showed preserved left ventricular systolic function.  He was admitted and placed on aspirin and colchicine.  A cardiac MRI today showed evidence of myopericarditis.  He had 3 beats of nonsustained VT on tele.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Individual with history of kidney transplant, on anti-rejection medication, scheduled a COVID-19 Pfizer vaccine. At the visit, the Individual was seen by the site medical evaluator prior to receiving first dose of vaccine which was administered on May 10, 2021. The individual did not mention receiving Moderna first dose (3/10/2021) and second (4/10/2021), nor indicated receiving a COVID vaccine on screening questions. Moderna  doses were administered by Pharmacy in. The site learned of the Moderna vax when speaking to the patient to obtain information. NYSDOH clinical team advised that the individual not receive the second dose of the COVID-19 Pfizer vaccine.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Pfizer vaccine mixed incorrectly (used sterile water)
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Skin warm, Swollen tongue
Clinical narrative: As soon as I received the shot and stood up, I immediately felt itchy all over, my body got warmer and then my tongue started to swell
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Heart rate increased
Clinical narrative: Patient reported feeling light headed and increased heart rate after the vaccine.
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Injection site erythema, Injection site paraesthesia, Rash, Rash macular
Clinical narrative: Patient is a 15-year-old, male. Alert, oriented X4, clear speech, able to answer to questions. No known medical history. History of anaphylaxis twice in past, requiring the use of epinephrine. History of allergies to peanuts, animal hair, and grass. At 11:43 am, the patient received his first dose of Pfizer (lot number EW0185, expires on 08/2021) on left deltoid. Patient walked with a steady, balanced gait to EMT observation area. At 12:00 pm, patient's mother notified EMT that patient had blotchy redness in left hand. Lead RN responded immediately and assessed the patient. Upon observation, the patient had localized redness at the injection site, with erythema on the entirety of his back and hands. Patient was assisted patient to anti-gravity chair. Patient states he feels "tingling" at injection site. Patient denied SOB, itching, and dizziness. Patient remained A&Ox4 and talking to EMT. RN requested vitals Q5 minutes for 30 minutes while she drew up 1.0 mL of IM Benadryl. At 12:02 pm: BP of 108/70, HR 78, SPO2 98%. At 12:08 pm, the redness and rash on patient's arm and back had completely subsided. Patient denies feeling tingling sensation at injection site. At 12:10 pm: BP of 110/67, HR 75, SPO2 99%. Patient's mother declined use of IM Benadryl. Lead RN education patient and mother on signs and symptoms of anaphylaxis, and requested the patient stay for an additional 20 minutes for monitoring. RN disposed of 1.0 mL dose of Benadryl. At 12:18 pm: BP of 110/70, HR 79, SPO2 99%. At 12:26 pm: BP of 108/70, HR 82, SPO2 99%. At 12:37 pm: BP of 106/70, HR 85, SPO2 97%. Lead RN provided patient's mother with education concerning when to call 9-1-1, including worsening of symptoms and trouble breathing. Patient was instructed to follow up with PCP and allergist. At 12:40 pm, patient stood up from chair, denied lightheadedness and dizziness. Patient walked to car with steady, balanced gait. Patient's mother drove patient home.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Blood urine, Dyspnoea, Haemoptysis, Hypoaesthesia, Peripheral swelling
Clinical narrative: Pt states that he woke up the next morning and his entire left arm was swollen and numb. The following day, two days after the vaccination, the entire left side of his body was swollen and numb. The patient went to the hospital on April 6, 2021, and was hospitalized for ten days. Upon admission, he had bloody urine, swelling and numbness on the left side of his body, and was short of breath and coughing up blood. Pt was diagnosed with pneumonia while admitted to hospital.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonia
Clinical narrative: Pt states that he woke up the next morning and his entire left arm was swollen and numb. The following day, two days after the vaccination, the entire left side of his body was swollen and numb. The patient went to the hospital on April 6, 2021, and was hospitalized for ten days. Upon admission, he had bloody urine, swelling and numbness on the left side of his body, and was short of breath and coughing up blood. Pt was diagnosed with pneumonia while admitted to hospital.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Pfizer vaccine mixed incorrectly (used sterile water
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Crying, Headache, Pain, Visual impairment
Clinical narrative: Patient developed changes in her vision that she reported as black dots on the left side of her vision that lasted roughly 2 minutes. She said she could not see out to the left side of her eye.  This went away after 2 minutes and within 20-30 minutes she developed a severe headache and was in tears from the pain. She has no history of headaches and this has never happened before. She did not report light or sound sensitivity. She did not have any vomiting, but did not want to eat. We consulted her Optometrist and Pediatrician. I gave her Naproxen and caffeine and within 3 hours her headache resolved.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Vomiting
Clinical narrative: Patient vomited approx a few minutes after vaccine was given. Patient slowly fell onto the ground from the standing position.  No injuries occured.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dizziness postural, Eye movement disorder, Muscle twitching, Tremor
Clinical narrative: Patient felt lightheaded after receiving vaccination, upon standing, lightheaded ness increased. She sat down and we propped up her feet and gave her water. She then began to tremor and her arms were twitching. Her eyes rolled back in her head and she was unresponsive to questions, but breathing was normal. With fanning and cold compress she recovered and EMS did not need to be called. The time of vaccination to recovery was about 5 minutes total.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Unresponsive to stimuli
Clinical narrative: Patient felt lightheaded after receiving vaccination, upon standing, lightheaded ness increased. She sat down and we propped up her feet and gave her water. She then began to tremor and her arms were twitching. Her eyes rolled back in her head and she was unresponsive to questions, but breathing was normal. With fanning and cold compress she recovered and EMS did not need to be called. The time of vaccination to recovery was about 5 minutes total.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory distress syndrome, Angiogram pulmonary abnormal, Aspergillus test negative, Asymptomatic COVID-19, Atrial fibrillation
Clinical narrative: Patient tested positive for COVID on April 12th after having received both COVID-19 vaccines - pfizer.  Patient has known COVID19 exposure from her son and was COVID19 positive in April. The patient had a positive asymptomatic COVID-19 test. Patient was tested prior to planned colonoscopy. The patient completed 10 days of quarantine until April 22.  Patient presented to hospital (sister hospital) on May 2nd after 1 week of fevers and productive cough. At MSQ patient received cefepime/vancomycin/doxycycline for CAP. She initially improved, but on 5/5 she had recurrent fever with rapid decline, her respiratory status requiring 2L of NC to HFNC to NRB.  CXR with B/L opacifications.  CTA chest was negative for PE, but patient with diffuse groundglass and consolidative opacities. Also had TTE that showed LVEF 71% and grade 1 diastolic dysfunction. She was evaluated by MSQ Infectious Diseases physician and was started on bactrim for PCP prophylaxis and resumed on broad spectrum antibiotics.  She was also evaluated by rheum in sitting of her SLE and patient was started on prednisone 40 mg q8h methylprednisolone for potential SLE flare. Continued on cefepime and vancomycin. Patient was transferred to Hospital due to worsening respiratory status and tested positive for COVID-19 at MSH on 5/9. Admitted to the MICU, patient received a loading dose and one 100 mg dose of remdesivir - stopped due to elevated liver enzymes.  On 5/16 extensive new ischemic/hemorrhagic strokes throughout intracranial vascular distribution, DIC d/t COVID vs AF and intubated for mental status changes. Patient's clinical picture worsening - requiring pressors. Chest x-ray with diffuse ground glass opacities, ARDs and pulmonary edema. Patient remains in critical condition in MICU as of 5/19.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood beta-D-glucan negative, Blood culture negative, Blood immunoglobulin G normal, Chest X-ray abnormal, Condition aggravated
Clinical narrative: Patient tested positive for COVID on April 12th after having received both COVID-19 vaccines - pfizer.  Patient has known COVID19 exposure from her son and was COVID19 positive in April. The patient had a positive asymptomatic COVID-19 test. Patient was tested prior to planned colonoscopy. The patient completed 10 days of quarantine until April 22.  Patient presented to hospital (sister hospital) on May 2nd after 1 week of fevers and productive cough. At MSQ patient received cefepime/vancomycin/doxycycline for CAP. She initially improved, but on 5/5 she had recurrent fever with rapid decline, her respiratory status requiring 2L of NC to HFNC to NRB.  CXR with B/L opacifications.  CTA chest was negative for PE, but patient with diffuse groundglass and consolidative opacities. Also had TTE that showed LVEF 71% and grade 1 diastolic dysfunction. She was evaluated by MSQ Infectious Diseases physician and was started on bactrim for PCP prophylaxis and resumed on broad spectrum antibiotics.  She was also evaluated by rheum in sitting of her SLE and patient was started on prednisone 40 mg q8h methylprednisolone for potential SLE flare. Continued on cefepime and vancomycin. Patient was transferred to Hospital due to worsening respiratory status and tested positive for COVID-19 at MSH on 5/9. Admitted to the MICU, patient received a loading dose and one 100 mg dose of remdesivir - stopped due to elevated liver enzymes.  On 5/16 extensive new ischemic/hemorrhagic strokes throughout intracranial vascular distribution, DIC d/t COVID vs AF and intubated for mental status changes. Patient's clinical picture worsening - requiring pressors. Chest x-ray with diffuse ground glass opacities, ARDs and pulmonary edema. Patient remains in critical condition in MICU as of 5/19.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Culture urine negative, Diastolic dysfunction, Disseminated intravascular coagulation, Echocardiogram, Echocardiogram abnormal
Clinical narrative: Patient tested positive for COVID on April 12th after having received both COVID-19 vaccines - pfizer.  Patient has known COVID19 exposure from her son and was COVID19 positive in April. The patient had a positive asymptomatic COVID-19 test. Patient was tested prior to planned colonoscopy. The patient completed 10 days of quarantine until April 22.  Patient presented to hospital (sister hospital) on May 2nd after 1 week of fevers and productive cough. At MSQ patient received cefepime/vancomycin/doxycycline for CAP. She initially improved, but on 5/5 she had recurrent fever with rapid decline, her respiratory status requiring 2L of NC to HFNC to NRB.  CXR with B/L opacifications.  CTA chest was negative for PE, but patient with diffuse groundglass and consolidative opacities. Also had TTE that showed LVEF 71% and grade 1 diastolic dysfunction. She was evaluated by MSQ Infectious Diseases physician and was started on bactrim for PCP prophylaxis and resumed on broad spectrum antibiotics.  She was also evaluated by rheum in sitting of her SLE and patient was started on prednisone 40 mg q8h methylprednisolone for potential SLE flare. Continued on cefepime and vancomycin. Patient was transferred to Hospital due to worsening respiratory status and tested positive for COVID-19 at MSH on 5/9. Admitted to the MICU, patient received a loading dose and one 100 mg dose of remdesivir - stopped due to elevated liver enzymes.  On 5/16 extensive new ischemic/hemorrhagic strokes throughout intracranial vascular distribution, DIC d/t COVID vs AF and intubated for mental status changes. Patient's clinical picture worsening - requiring pressors. Chest x-ray with diffuse ground glass opacities, ARDs and pulmonary edema. Patient remains in critical condition in MICU as of 5/19.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Endotracheal intubation, Haemorrhagic stroke, Hepatic enzyme increased, Immunology test, Influenza A virus test negative
Clinical narrative: Patient tested positive for COVID on April 12th after having received both COVID-19 vaccines - pfizer.  Patient has known COVID19 exposure from her son and was COVID19 positive in April. The patient had a positive asymptomatic COVID-19 test. Patient was tested prior to planned colonoscopy. The patient completed 10 days of quarantine until April 22.  Patient presented to hospital (sister hospital) on May 2nd after 1 week of fevers and productive cough. At MSQ patient received cefepime/vancomycin/doxycycline for CAP. She initially improved, but on 5/5 she had recurrent fever with rapid decline, her respiratory status requiring 2L of NC to HFNC to NRB.  CXR with B/L opacifications.  CTA chest was negative for PE, but patient with diffuse groundglass and consolidative opacities. Also had TTE that showed LVEF 71% and grade 1 diastolic dysfunction. She was evaluated by MSQ Infectious Diseases physician and was started on bactrim for PCP prophylaxis and resumed on broad spectrum antibiotics.  She was also evaluated by rheum in sitting of her SLE and patient was started on prednisone 40 mg q8h methylprednisolone for potential SLE flare. Continued on cefepime and vancomycin. Patient was transferred to Hospital due to worsening respiratory status and tested positive for COVID-19 at MSH on 5/9. Admitted to the MICU, patient received a loading dose and one 100 mg dose of remdesivir - stopped due to elevated liver enzymes.  On 5/16 extensive new ischemic/hemorrhagic strokes throughout intracranial vascular distribution, DIC d/t COVID vs AF and intubated for mental status changes. Patient's clinical picture worsening - requiring pressors. Chest x-ray with diffuse ground glass opacities, ARDs and pulmonary edema. Patient remains in critical condition in MICU as of 5/19.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Influenza B virus test, Intensive care, Ischaemic stroke, Lung consolidation, Lung opacity
Clinical narrative: Patient tested positive for COVID on April 12th after having received both COVID-19 vaccines - pfizer.  Patient has known COVID19 exposure from her son and was COVID19 positive in April. The patient had a positive asymptomatic COVID-19 test. Patient was tested prior to planned colonoscopy. The patient completed 10 days of quarantine until April 22.  Patient presented to hospital (sister hospital) on May 2nd after 1 week of fevers and productive cough. At MSQ patient received cefepime/vancomycin/doxycycline for CAP. She initially improved, but on 5/5 she had recurrent fever with rapid decline, her respiratory status requiring 2L of NC to HFNC to NRB.  CXR with B/L opacifications.  CTA chest was negative for PE, but patient with diffuse groundglass and consolidative opacities. Also had TTE that showed LVEF 71% and grade 1 diastolic dysfunction. She was evaluated by MSQ Infectious Diseases physician and was started on bactrim for PCP prophylaxis and resumed on broad spectrum antibiotics.  She was also evaluated by rheum in sitting of her SLE and patient was started on prednisone 40 mg q8h methylprednisolone for potential SLE flare. Continued on cefepime and vancomycin. Patient was transferred to Hospital due to worsening respiratory status and tested positive for COVID-19 at MSH on 5/9. Admitted to the MICU, patient received a loading dose and one 100 mg dose of remdesivir - stopped due to elevated liver enzymes.  On 5/16 extensive new ischemic/hemorrhagic strokes throughout intracranial vascular distribution, DIC d/t COVID vs AF and intubated for mental status changes. Patient's clinical picture worsening - requiring pressors. Chest x-ray with diffuse ground glass opacities, ARDs and pulmonary edema. Patient remains in critical condition in MICU as of 5/19.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mental status changes, Mycobacterium tuberculosis complex test negative, Pneumonia, Productive cough, Pulmonary oedema
Clinical narrative: Patient tested positive for COVID on April 12th after having received both COVID-19 vaccines - pfizer.  Patient has known COVID19 exposure from her son and was COVID19 positive in April. The patient had a positive asymptomatic COVID-19 test. Patient was tested prior to planned colonoscopy. The patient completed 10 days of quarantine until April 22.  Patient presented to hospital (sister hospital) on May 2nd after 1 week of fevers and productive cough. At MSQ patient received cefepime/vancomycin/doxycycline for CAP. She initially improved, but on 5/5 she had recurrent fever with rapid decline, her respiratory status requiring 2L of NC to HFNC to NRB.  CXR with B/L opacifications.  CTA chest was negative for PE, but patient with diffuse groundglass and consolidative opacities. Also had TTE that showed LVEF 71% and grade 1 diastolic dysfunction. She was evaluated by MSQ Infectious Diseases physician and was started on bactrim for PCP prophylaxis and resumed on broad spectrum antibiotics.  She was also evaluated by rheum in sitting of her SLE and patient was started on prednisone 40 mg q8h methylprednisolone for potential SLE flare. Continued on cefepime and vancomycin. Patient was transferred to Hospital due to worsening respiratory status and tested positive for COVID-19 at MSH on 5/9. Admitted to the MICU, patient received a loading dose and one 100 mg dose of remdesivir - stopped due to elevated liver enzymes.  On 5/16 extensive new ischemic/hemorrhagic strokes throughout intracranial vascular distribution, DIC d/t COVID vs AF and intubated for mental status changes. Patient's clinical picture worsening - requiring pressors. Chest x-ray with diffuse ground glass opacities, ARDs and pulmonary edema. Patient remains in critical condition in MICU as of 5/19.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, SARS-CoV-2 antibody test negative, SARS-CoV-2 test positive
Clinical narrative: Patient tested positive for COVID on April 12th after having received both COVID-19 vaccines - pfizer.  Patient has known COVID19 exposure from her son and was COVID19 positive in April. The patient had a positive asymptomatic COVID-19 test. Patient was tested prior to planned colonoscopy. The patient completed 10 days of quarantine until April 22.  Patient presented to hospital (sister hospital) on May 2nd after 1 week of fevers and productive cough. At MSQ patient received cefepime/vancomycin/doxycycline for CAP. She initially improved, but on 5/5 she had recurrent fever with rapid decline, her respiratory status requiring 2L of NC to HFNC to NRB.  CXR with B/L opacifications.  CTA chest was negative for PE, but patient with diffuse groundglass and consolidative opacities. Also had TTE that showed LVEF 71% and grade 1 diastolic dysfunction. She was evaluated by MSQ Infectious Diseases physician and was started on bactrim for PCP prophylaxis and resumed on broad spectrum antibiotics.  She was also evaluated by rheum in sitting of her SLE and patient was started on prednisone 40 mg q8h methylprednisolone for potential SLE flare. Continued on cefepime and vancomycin. Patient was transferred to Hospital due to worsening respiratory status and tested positive for COVID-19 at MSH on 5/9. Admitted to the MICU, patient received a loading dose and one 100 mg dose of remdesivir - stopped due to elevated liver enzymes.  On 5/16 extensive new ischemic/hemorrhagic strokes throughout intracranial vascular distribution, DIC d/t COVID vs AF and intubated for mental status changes. Patient's clinical picture worsening - requiring pressors. Chest x-ray with diffuse ground glass opacities, ARDs and pulmonary edema. Patient remains in critical condition in MICU as of 5/19.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: The patient stated that she felt dizzy. She laid down. The nurse attended her and took her vitals. BP 112/85, O2 =99, HR=87.  The patient state that she was ok.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Chest pain, Chills, Condition aggravated, Continuous positive airway pressure
Clinical narrative: ED to Hosp-Admission Discharged  3/28/2021 - 3/29/2021 (30 hours)    Last attending ? Treatment team Pneumonia due to COVID-19 virus Principal problem  Discharge Diagnosis Hospital Problems          POA   * (Principal) Pneumonia due to COVID-19 virus Unknown       Type 2 diabetes mellitus without complication, without long-term current use of insulin (CMS/HCC) Yes       Obstructive sleep apnea syndrome Yes       Restrictive lung disease Yes       Morbid obesity due to excess calories (CMS/HCC) Yes       Prostate cancer (CMS/HCC) Yes       Status post radiation therapy Not Applicable       COVID-19 virus detected Yes     Hospital Course    COVID-19 Pneumonia Patient presented with headache, chills, diarrhea, dry cough and rash. Patient was maintaining saturation of 91-92% at rest and was desaturating down to 88-89% on slightest exertion. Patient was started on oral dexamethasone 6 mg daily and remdesivir therapy. Patient left AMA on Day 2 admission. Patient was provided 10 days of dexamethasone therapy.    Atopic Rash Likely secondary to COVID-19 infection or allergic reaction. Rash responded well to Benadryl therapy initially.  Patient reported reappearance of rash the next day. Patient was continued on Benadryl PRN.   Chest Pain, Resolved  Heart score of 3.  EKG unremarkable for ischemic changes. Clinical suspicion for angina was low.   Type 2 Diabetes Most recent HbA1c of 7.8 on 11/2020. Patient is on home glipizide therapy. Patient started on 8 units of Lantus nightly and low-dose sliding scale.   Essential Hypertension Patient is on lisinopril 20 mg therapy at home. Home dose of lisinopril resumed   Possible obesity hypoventilation syndrome Possible COPD Previous note by pulmonologist reflects that patient's disease might be restrictive instead of obstructive however as he had responded to inhalers, inhalers were continued. Patient's home Incruse Ellipta was resumed. DuoNebs as needed were given.   Obstructive Sleep Apnea  Patient uses CPAP at night. CPAP ordered to be used nightly during hospital stay   Major depressive disorder Symptoms are well controlled on Prozac therapy. Home dose of Prozac resumed   Hypercholesterolemia Home dose of atorvastatin 40 mg resumed   Morbid Obesity